Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2019 May 1;33(6):1083-1088.
doi: 10.1097/QAD.0000000000002127.

Differences in the rate of nicotine metabolism among smokers with and without HIV

Rebecca L Ashare  1 , Morgan Thompson  1 , Frank Leone  2 , David Metzger  1 , Robert Gross  3   4 , Karam Mounzer  5 , Rachel F Tyndale  6 , Caryn Lerman  1 , Martin C Mahoney  7 , Paul Cinciripini  8 , Tony P George  9 , Ronald G Collman  10 , Robert Schnoll  1
Affiliations
Comparative Study

Differences in the rate of nicotine metabolism among smokers with and without HIV

Rebecca L Ashare et al. AIDS. .

Abstract

Objective: HIV-infected smokers lose more life years to tobacco use than to HIV infection. The nicotine metabolite ratio (NMR), a biomarker of CYP2A6, represents individual variation in the rate at which nicotine is metabolized and is associated with response to smoking cessation treatments. We evaluated whether HIV-infected smokers metabolize nicotine faster than HIV-uninfected smokers, which may contribute to the disproportionate smoking burden and may have important treatment implications.

Design: We analysed baseline data from two clinical trials (NCT01710137; NCT01314001) to compare the NMR in HIV-infected smokers (N = 131) to HIV-uninfected smokers (N = 199).

Methods: Propensity scores were used to match the groups 2 : 1 on characteristics that influence NMR: sex, race, BMI and smoking rate. Nicotine metabolites were assessed via liquid chromatography-tandem mass spectrometry methods and the ratio of 3-hydroxycotinine:cotinine was used to compute the NMR.

Results: HIV-infected smokers had significantly higher NMR (mean = 0.47, SEM = 0.02) and were more likely to be in the highest NMR quartile compared with HIV-uninfected smokers (mean = 0.34, SEM = 0.02; Ps < 0.001).

Conclusion: The higher NMR observed among HIV-infected smokers may partially explain higher smoking rates and lower response to transdermal nicotine therapy. Understanding the mechanisms by which HIV and/or ART contribute to faster nicotine metabolism may guide the use of the NMR to personalize tobacco cessation strategies in this underserved population.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Dr. Schnoll receives medication and placebo free of charge from Pfizer for clinical trials and has provided consultation to Pfizer, GlaxoSmithKline, and Curaleaf. Dr. Gross serves on a Pfizer Data and Safety Monitoring Board for a drug unrelated to smoking or HIV. Dr. Ashare has an investigator-initiated grant from Novo Nordisk for a drug unrelated to the current study. Dr. Tyndale has consulted for Quinn Emmanual, Apotex and Ethismos.

Figures

Figure 1.
Figure 1.. NMR Quartile by HIV Status in Matched Sample.
There were significantly more HIV-infected smokers (35%) characterized as fastest metabolizers (4th quartile) compared to HIV-uninfected smokers (17%). In contrast, 47% of HIV-uninfected smokers were characterized as the slowest metabolizers compared to 29% of HIV-infected smokers.
See this image and copyright information in PMC

References

    1. Crothers K, Griffith TA, McGinnis KA, Rodriguez-Barradas MC, Leaf DA, Weissman S, et al. The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. J Gen Intern Med 2005; 20(12):1142–1145. - PMC - PubMed
    1. Feldman JG, Minkoff H, Schneider MF, Gange SJ, Cohen M, Watts DH, et al. Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women’s interagency HIV study. Am J Public Health 2006; 96(6):1060–1065. - PMC - PubMed
    1. Webb MS, Vanable PA, Carey MP, Blair DC. Cigarette smoking among HIV+ men and women: examining health, substance use, and psychosocial correlates across the smoking spectrum. J Behav Med 2007; 30(5):371–383. - PMC - PubMed
    1. Collins RL, Kanouse DE, Gifford AL, Senterfitt JW, Schuster MA, McCaffrey DF, et al. Changes in health-promoting behavior following diagnosis with HIV: prevalence and correlates in a national probability sample. Health Psychol 2001; 20(5):351–360. - PubMed
    1. Burkhalter JE, Springer CM, Chhabra R, Ostroff JS, Rapkin BD. Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine Tob Res 2005; 7(4):511–522. - PubMed

Publication types

Associated data